CN Patent

CN110003033B — 氟比洛芬查尔酮曼尼希碱类化合物、其制备方法和用途

Assigned to Sichuan University · Expires 2021-06-18 · 5y expired

What this patent protects

本发明公开了一类氟比洛芬查尔酮曼尼希碱类化合物（I）及其药学上可接受的盐、其制备方法、药物组合物和在制备治疗和/或预防神经退行性相关疾病药物中的用途，包括但不限于血管性痴呆、阿尔茨海默氏症、帕金森症、亨廷顿症、HIV相关痴呆症、多发性硬化症、进行性脊髓侧索硬化症、神经性疼痛、青光眼等神经退行性疾病；

USPTO Abstract

本发明公开了一类氟比洛芬查尔酮曼尼希碱类化合物（I）及其药学上可接受的盐、其制备方法、药物组合物和在制备治疗和/或预防神经退行性相关疾病药物中的用途，包括但不限于血管性痴呆、阿尔茨海默氏症、帕金森症、亨廷顿症、HIV相关痴呆症、多发性硬化症、进行性脊髓侧索硬化症、神经性疼痛、青光眼等神经退行性疾病；

Drugs covered by this patent

trazodone-hydrochloride (TRAZODONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN110003033B
Jurisdiction: CN
Classification: —
Expires: 2021-06-18
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.